. One of the animal models that is used to study AD and aging is the senescence-accelerated mouse (SAM). The SAM model was developed in 1981, which originally consisted of nine major senescence-accelerated-prone mice (SAMP)
substrains and three major senescence-accelerated-resistant mice (SAMR) substrains, each of which exhibits the characteristic disorders.
Methodology
As in vitro experiment, the human neuroblastoma clonal SH-SY5Y cell were maintained at 37°C under 5% CO 2 / 95% air. As in vivo experiment, the CQA-treated mice were orally administered with 3,5-di-O-CQA mixed with drinking water (6.7 mg/kg · day) for 1 month using oral administration tube and syringe. Proteomics analysis, real-time PCR, measurement of intracellular ATP content, Moris water maze were carried out to investigate the neuroprotective effect of CQA. 3,5-di-O-CQA had neuroprotective effect on Aβ 1-42 treated cells. The mRNA expression of glycolytic enzyme (phosphoglycerate kinase-1; PGK1) and intracellular ATP level were increased in CQA treated SH-SY5Y cells. We also found that CQA administration induced the improvement of spatial learning and memory on SAMP8 mice, and the overexpression of PGK1 mRNA.
Conclusion
CQA has a neuroprotective effect on Aβ 1-42 treated SH-SY5Y cells. The mRNA expression of glycolytic enzyme (PGK1) and the intracellular ATP level were increased in CQA-treated SH-SY5Y cells. We also found that CQA administration induced the improvement of spatial learning and memory on SAMP8 mice, and the overexpression of PGK1 mRNA level. These findings suggest that CQA has a neuroprotective effect through the induction of PGK1 expression and ATP production activation. 
